In liver cancer models, curcumin reduces HK2 expression by inhibiting the activity of CSN5 kinase, which decreases glycolytic flux and invasive capacity, effectively prolonging the survival of tumor-bearing animals [27]. Here, HK2 is linked to neoplasm.